Core Viewpoint - Intel's stock has experienced one of its best years in the past two decades and is expected to continue gaining momentum according to a newly optimistic analyst [1] Group 1 - Intel's stock performance has significantly improved, marking a notable recovery in the company's market position [1] - The bullish outlook from analysts suggests that there are further growth opportunities for Intel in the near future [1]

Group 1 - An affiliate of Paul Singer's Elliott Management successfully won an auction for Citgo late last year [1]

Gold and silver emerged as the big winners of flight-to-safety trades by investors on Monday following the U.S. intervention in Venezuela. ...

Group 1 - The early ratings for Versant indicate a significant decline in share value, with a drop of nearly 15% for the new owner of major cable television networks such as CNBC, USA Network, and MS NOW (formerly MSNBC) [1]

The company is poised to close with a market capitalization of more than $900 billion, putting it in an exclusive group —Â and one in which its stock is the cheapest. ...

The semiconductor trade was mostly riding high on Monday as enthusiasm for the artificial-intelligence boom carried into the new year. ...

In September 1987, Donald Trump paid $94,801 for full-page advertisements in the New York Times, the Washington Post and the Boston Globe. He was 41 years old, not yet a politician. ...

Core Insights - Novo Nordisk has launched the first GLP-1 pill for weight loss in the U.S., marking a significant advancement in obesity treatment [1] Group 1: Product Launch - The new obesity medicine from Novo Nordisk is now available in pill form, expanding treatment options for patients [1] - This launch represents a major milestone as it is the first oral GLP-1 medication approved for weight loss in the U.S. [1] Group 2: Market Impact - The introduction of the pill is expected to enhance accessibility for patients who may prefer oral medications over injections [1] - This development could potentially increase the market share of Novo Nordisk in the obesity treatment sector [1]

Core Viewpoint - Investors are advised to be selective in the volatile software sector, yet analysts identify significant opportunities in both well-known stocks and lesser-known companies [1] Group 1 - The software sector remains choppy, indicating a need for careful investment strategies [1] - Analysts highlight compelling opportunities in high-profile stocks, suggesting potential for growth [1] - There are also under-the-radar plays that may offer attractive investment prospects [1]

ASML shares rallied on Monday to make the stock one of the strongest-performing members of the Nasdaq 100 after an analyst upgrade due to demand from memory-chip producers. ...